# Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood

> **NCT00978705** · PHASE3 · UNKNOWN · sponsor: **Biosolution Co., Ltd.** · enrollment: 19 (estimated)

## Conditions studied

- Burn Wound

## Interventions

- **DRUG:** Autologous cultured keratinocyte cell

## Key facts

- **NCT ID:** NCT00978705
- **Lead sponsor:** Biosolution Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** 2008-05
- **Final completion:** 2010-01
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2009-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978705, "Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00978705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*